Generation of a Matrix Gla (Mgp) floxed mouse, followed by conditional knockout, uncovers a new Mgp function in the eye

The ability to ablate a gene in a given tissue by generating a conditional knockout (cKO) is crucial for determining its function in the targeted tissue. Such tissue-specific ablation is even more critical when the gene's conventional knockout (KO) is lethal, which precludes studying the consequences of its deletion in other tissues. Therefore, here we describe a successful strategy that generated a Matrix Gla floxed mouse (Mgp.floxed) by the CRISPR/Cas9 system, that subsequently allowed the generation of cKOs by local viral delivery of the Cre-recombinase enzyme. MGP is a well-established inhibitor of calcification gene, highly expressed in arteries' smooth muscle cells and chondrocytes. MGP is also one of the most abundant genes in the trabecular meshwork, the eye tissue responsible for maintenance of intraocular pressure (IOP) and development of Glaucoma. Our strategy entailed one-step injection of two gRNAs, Cas9 protein and a long-single-stranded-circular DNA donor vector (lsscDNA, 6.7 kb) containing two loxP sites in cis and 900-700 bp 5'/3' homology arms. Ocular intracameral injection of Mgp.floxed mice with a Cre-adenovirus, led to an Mgp.TMcKO mouse which developed elevated IOP. Our study discovered a new role for the Mgp gene as a keeper of physiological IOP in the eye.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Scientific reports - 10(2020), 1 vom: 29. Okt., Seite 18583

Sprache:

Englisch

Beteiligte Personen:

Borrás, Teresa [VerfasserIn]
Cowley, Dale O [VerfasserIn]
Asokan, Priyadarsini [VerfasserIn]
Pandya, Kumar [VerfasserIn]

Links:

Volltext

Themen:

Calcium-Binding Proteins
Cre recombinase
EC 2.7.7.-
Extracellular Matrix Proteins
Integrases
Journal Article
RNA, Guide, CRISPR-Cas Systems
Research Support, N.I.H., Extramural

Anmerkungen:

Date Completed 19.03.2021

Date Revised 04.01.2024

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41598-020-75031-7

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM316913138